Dr. Reddy’s Laboratories Ltd. (DRREDDY): Dr. Reddy’s Laboratories Share Price Rises 2.37% Today
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Dr. Reddy’s Laboratories Share Price moved higher today to Rs 1,172.35, up 2.37% from the previous close of Rs 1,145.25, with market capitalisation at Rs 95,967.37 crore. The stock opened at Rs 1140.50, touched an intraday high of Rs 1,176.75 and a low of Rs 1140.50, while turnover stood at Rs 11.81 crore. This is a same-day share price rise, and the supplied data confirms the event but does not establish a company-specific catalyst. For readers following Dr. Reddy’s Laboratories Share Price Today, the move is relevant because it comes alongside a sizeable listed-company base in the Healthcare sector and a valuation profile that can be compared with peers on Univest.
In today’s Dr. Reddy’s Laboratories Stock News flow, the main question is not only what changed in price but also how the stock sits versus its industry benchmarks. Univest is tracking the move through price action, financial ratios and peer context so investors can read the day’s gain in a factual, market-led way.
Dr. Reddy’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,172.35 |
| Previous Close | Rs 1,145.25 |
| Today's Move | Rs 27.1 (+2.37%) |
| Open | Rs 1,140.5 |
| High | Rs 1,176.75 |
| Low | Rs 1,140.5 |
| Turnover | Rs 11.81 crore |
| Market Capitalisation | Rs 95,967.37 crore |
| Market Cap Category | Large Cap |
Dr. Reddy's Laboratories Ltd. (DRREDDY) rose to Rs 1,172.35 from the previous close of Rs 1,145.25, a move of Rs 27.1 or 2.37%. The stock opened at Rs 1,140.5, reached a high of Rs 1,176.75, recorded a low of Rs 1,140.5.
Dr. Reddy’s Laboratories Share Price Today gained Rs 27.10, or 2.37%, after opening at Rs 1140.50 and closing the session at Rs 1,172.35. The day’s range of Rs 1140.50 to Rs 1,176.75 shows the stock traded above its opening level for most of the move, and the turnover of Rs 11.81 crore gives a factual measure of traded value. The previous close was Rs 1,145.25, so the stock finished Rs 27.10 higher on the day. In today’s Stock Market Today context, Dr. Reddy’s Laboratories appears among Stocks in News because of the share price rise itself, not because the supplied data assigns a catalyst. Univest users tracking Dr. Reddy’s Laboratories Share Price Live can focus on the day’s exact numbers rather than speculation.
Dr. Reddy's Laboratories Ltd. (DRREDDY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 95,967.37 crore |
| P/E Ratio | 29.67x |
| P/B Ratio | 2.5x |
| ROE | 11.69% |
| ROCE | 13.75% |
| EPS | Rs 38.6 |
| Book Value Per Share | Rs 457.39 |
| Dividend Yield | 0.7% |
Dr. Reddy's Laboratories Ltd. (DRREDDY) fundamental metrics show P/E 29.67x, P/B 2.5x, ROE 11.69%, ROCE 13.75%. These figures provide context only and are not a buy or sell signal.
Dr. Reddy’s Laboratories Ltd. has a market capitalisation of Rs 95967.37 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.67x, P/B at 2.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.69% and ROCE of 13.75%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 38.6, book value per share of Rs 457.39, dividend yield of 0.7%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.67x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 2.5x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 11.69% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 13.75% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 95,967.37 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Dr. Reddy's Laboratories Ltd. (DRREDDY) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 29.67x, which is below the benchmark median of 31.35x, a difference of -5.36%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROE of 11.69%, which is below the benchmark median of 11.78%, a difference of -0.76%. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROCE of 13.75%, which is above the benchmark median of 13.65%, a difference of +0.73%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 29.67x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.75% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a market capitalisation of Rs 95,967.37 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Dr. Reddy’s Laboratories
- Dr. Reddy’s Laboratories Share Price rose 2.37% today to Rs 1,172.35 from Rs 1,145.25.
- The stock’s market capitalisation is Rs 95,967.37 crore, placing it well above the same-industry median.
- P/E at 29.67 is below the same-industry median of 31.35 and below the average of 47.81.
- ROE is 11.69% and ROCE is 13.75%, both close to the benchmark range for the industry.
- EPS is Rs 38.60, book value is Rs 457.39 and dividend yield is 0.7%, giving added fundamental context.
About Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories Ltd. is a Healthcare company in the Pharmaceuticals & Drugs industry. The business is known for its presence across pharmaceutical products and related healthcare offerings, and it is tracked by investors through NSE and BSE market data. The current market capitalisation of Rs 95,967.37 crore shows that it is a large listed healthcare name within the supplied same-industry benchmark set.
From a stock analysis perspective, the company’s business profile matters because price changes often get read alongside operating and valuation metrics. Dr. Reddy’s Laboratories Fundamental Analysis today includes P/E, P/B, ROE, ROCE, EPS, book value and dividend yield, which help place the latest share price in a broader company context. Univest tracks the company alongside other Healthcare and Pharmaceuticals & Drugs peers so readers can compare the share price move with sector valuation, peer position and market-cap scale.
Track Dr. Reddy’s Laboratories Share Price on Univest
Use Dr. Reddy's Laboratories Ltd. (DRREDDY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Dr. Reddy’s Laboratories Share Price on Univest for live share price updates, financial ratios, shareholding pattern, 52-week levels and market insights. The same page also brings together stock news, fundamental analysis and peer context so you can review Dr. Reddy’s Laboratories Share Price Today in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Dr. Reddy's Laboratories share price rise today?
Ans. The supplied data confirms a 2.37% price rise, but it does not establish a company-specific catalyst. The stock ended at Rs 1,172.35 versus a previous close of Rs 1,145.25. The previous close was Rs 1,145.25.
What is Dr. Reddy's Laboratories Share Price today?
Ans. Dr. Reddy's Laboratories Share Price today is Rs 1,172.35. It rose Rs 27.10, or 2.37%, during the session and traded between Rs 1,140.50 and Rs 1,176.75. The previous close was Rs 1,145.25.
What is the market capitalisation of Dr. Reddy's Laboratories?
Ans. The company’s market capitalisation is Rs 95,967.37 crore. That places Dr. Reddy's Laboratories above the same-industry median and average market-cap figures supplied for the benchmark universe. The company operates in the Healthcare sector.
How does Dr. Reddy's Laboratories look on valuation?
Ans. Dr. Reddy's Laboratories has a P/E ratio of 29.67 and a P/B ratio of 2.5. Both are below the same-industry benchmark median and average, which provides useful valuation context. The company trades at a P/E ratio of 29.67x.
What do EPS, book value and dividend yield show for Dr. Reddy's Laboratories?
Ans. EPS is Rs 38.60, book value is Rs 457.39 and dividend yield is 0.7%. Together they help readers assess earnings, accounting net worth and the historical payout relative to the current share price.
How do ROE and ROCE compare for Dr. Reddy's Laboratories?
Ans. ROE is 11.69% and ROCE is 13.75%. Both figures are close to the supplied same-industry benchmark and give a steady profitability reference for Dr. Reddy's Laboratories Stock Analysis. ROE stands at 11.69%.
How does Dr. Reddy's Laboratories compare with peers?
Ans. Dr. Reddy's Laboratories sits in the middle of the supplied peer set on P/E, while its market cap is similar to Aurobindo Pharma and Lupin. Its ROE and ROCE are below several higher-return peers.
Where can investors track Dr. Reddy's Laboratories share price live?
Ans. Investors can track Dr. Reddy's Laboratories Share Price Live on Univest. The stock page brings together price updates, financial ratios, market-cap context and peer comparison in a single view. The previous close was Rs 1,145.25.
